Sfoglia per Autore
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C.
2010 Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenzi A; Bernardi M; Andreone P.
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B
2010 Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C.
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis.
2011 Fiorino S; Cursaro C; Lorenzini S; Loggi E; Brodosi L; Cattani L; Cuppini A; Bernardi M; Andreone P.
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients
2011 Gramenzi A; Loggi E; Micco L; Cursaro C; Fiorino S; Galli S; Gitto S; Galli C; Furlini G; Bernardi M; Andreone P.
Vitamins in the treatment of chronic viral hepatitis.
2011 Fiorino S; Conti F; Gramenzi A; Loggi E; Cursaro C; Di Donato R; Micco L; Gitto S; Cuppini A; Bernardi M; Andreone P.
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium.
2012 Grossi PA.; Costa AN.; Fehily D.; Blumberg EA.; Kuehnert MJ.; Fishman JA.; Ison MG.; Lattes R.; Kotton CN.; Lilleri D.; Kabanova A.; Lanzavecchia A.; Gerna G.; Razonable RR.; Comoli P.; Zecca M.; Basso S.; Ginevri F.; Grossi A.; Schena FP.; Rimola A.; Burra P.; De Martin E.; Rodriguez-Castro KI.; Fagiuoli S.; Pasulo L.; Bruno R.; Andreone P.; Loggi E.; Arena F.; Maria Rossolini G.; Sganga G.; Cozza V.
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
2012 Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Nanni Costa A; Pinna AD; Brander C; Andreone P.
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C.
2012 Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M.; Brillanti S.; Andreone P.
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis
2012 Daniela Buccione; Gianluca Fatti; Andrea Gallotta; Elisabetta Loggi; Roberto Di Donato; Lilia Testa; Carlo Saitta; Valentina Santi; Antonio Di Micoli; Virginia Erroi; Marta Frigerio; Valentina Fazio; Antonino Picciotto; Alessandra Biasiolo; Francoise Degos; Patrizia Pontisso; Giovanni Raimondo; Franco Trevisani
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV.
2012 Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.; Vandelli C.; Andreone P.; Missale G.; Ferrari C.
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects.
2013 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A.F. Cicero, M. Bernardi, P. Andreone
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C.
2013 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, R. Vukotic, E. Loggi, L. Pirillo, A.F. Cicero, M. Bernardi, P. Andreone
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
2013 Loggi E; Bihl FK; Cursaro C; Granieri C; Galli S; Brodosi L; Furlini G; Bernardi M; Brander C; Andreone P.
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.
2013 Loggi E; Cursaro C; Scuteri A; Grandini E; Panno AM; Galli S; Furlini G; Bernardi M; Galli C; Andreone P.
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
2013 Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK.
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin.
2014 Conti F; Vukotic R; Lorenzini S; Riili A; Cursaro C; Scuteri A; Loggi E; Galli S; Furlini G; Bernardi M; Andreone P.
Adaptive response in Hepatitis B virus infection
2014 Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P.
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients.
2014 Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P.
Chronic hepatitis B: Are we close to a cure?
2015 Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone .
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies
2015 Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. | Grandini E; Cannoletta F; Scuteri A; Fortini C; Loggi E; Cursaro C; Riili A; Di Donato R; Gramenz...i A; Bernardi M; Andreone P. | 2010-01-01 | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | - | 1.01 Articolo in rivista | - |
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B | Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreo...ne P; Missale G; Ferrari C. | 2010-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. | Fiorino S; Cursaro C; Lorenzini S; Loggi E; Brodosi L; Cattani L; Cuppini A; Bernardi M; Andreone P. | 2011-01-01 | THE ITALIAN JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients | Gramenzi A; Loggi E; Micco L; Cursaro C; Fiorino S; Galli S; Gitto S; Galli C; Furlini G; Bernard...i M; Andreone P. | 2011-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
Vitamins in the treatment of chronic viral hepatitis. | Fiorino S; Conti F; Gramenzi A; Loggi E; Cursaro C; Di Donato R; Micco L; Gitto S; Cuppini A; Ber...nardi M; Andreone P. | 2011-01-01 | BRITISH JOURNAL OF NUTRITION | - | 1.01 Articolo in rivista | - |
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. | Grossi PA.; Costa AN.; Fehily D.; Blumberg EA.; Kuehnert MJ.; Fishman JA.; Ison MG.; Lattes R.; K...otton CN.; Lilleri D.; Kabanova A.; Lanzavecchia A.; Gerna G.; Razonable RR.; Comoli P.; Zecca M.; Basso S.; Ginevri F.; Grossi A.; Schena FP.; Rimola A.; Burra P.; De Martin E.; Rodriguez-Castro KI.; Fagiuoli S.; Pasulo L.; Bruno R.; Andreone P.; Loggi E.; Arena F.; Maria Rossolini G.; Sganga G.; Cozza V. | 2012-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. | Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; G...rossi P; Nanni Costa A; Pinna AD; Brander C; Andreone P. | 2012-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. | Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M....; Brillanti S.; Andreone P. | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis | Daniela Buccione; Gianluca Fatti; Andrea Gallotta; Elisabetta Loggi; Roberto Di Donato; Lilia Tes...ta; Carlo Saitta; Valentina Santi; Antonio Di Micoli; Virginia Erroi; Marta Frigerio; Valentina Fazio; Antonino Picciotto; Alessandra Biasiolo; Francoise Degos; Patrizia Pontisso; Giovanni Raimondo; Franco Trevisani | 2012-01-01 | OPEN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. | Fisicaro P.; Valdatta C.; Massari M.; Loggi E.; Ravanetti L.; Urbani S.; Giuberti T.; Cavalli A.;... Vandelli C.; Andreone P.; Missale G.; Ferrari C. | 2012-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. | G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A....F. Cicero, M. Bernardi, P. Andreone | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 4.01 Contributo in Atti di convegno | - |
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. | G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, R. Vukotic, ...E. Loggi, L. Pirillo, A.F. Cicero, M. Bernardi, P. Andreone | 2013-01-01 | MEDICINA PSICOSOMATICA | - | 4.01 Contributo in Atti di convegno | - |
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. | Loggi E; Bihl FK; Cursaro C; Granieri C; Galli S; Brodosi L; Furlini G; Bernardi M; Brander C; An...dreone P. | 2013-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | PlosOne HBV.pdf |
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. | Loggi E; Cursaro C; Scuteri A; Grandini E; Panno AM; Galli S; Furlini G; Bernardi M; Galli C; And...reone P. | 2013-01-01 | JOURNAL OF CLINICAL VIROLOGY | - | 1.01 Articolo in rivista | - |
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. | Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; B...ihl F; Andreone P; Maini MK. | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. | Conti F; Vukotic R; Lorenzini S; Riili A; Cursaro C; Scuteri A; Loggi E; Galli S; Furlini G; Bern...ardi M; Andreone P. | 2014-01-01 | ANNALS OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
Adaptive response in Hepatitis B virus infection | Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P. | 2014-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. | Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P. | 2014-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
Chronic hepatitis B: Are we close to a cure? | Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone . | 2015-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies | Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina...; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda | 2015-01-01 | HEPATOLOGY INTERNATIONAL | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile